Cerebellum
8
3
3
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
13%
1 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (8)
Examining Lateralized Aspects of Motor Control Using Non-invasive Neural Stimulation
Advantage of Cerebellar Transcranial Magnetic Stimulation in Alzheimer's Diseases （ACT-AD）
Imaging Speech in Neurotypical Adults and Individuals With Cerebellar Stroke
The Study on the Efficacy of tDCS Stimulation of the Cerebellum Combined With XingNaoJing Injection in Patients With Consciousness Disorders After Cranial Injury
Effects of 3-Month Melatonin Treatment on Regional Cerebellar Structure and Blood Biomarkers in Alzheimer's Disease Spectrum
The Mechanism of cTBS Targeting Dentate Nucleus for DRE
Cerebellar Transcranial Direct Current Stimulation in Parkinson's Disease
Association Between Balance and the Integrity of Cerebellar White Matter Tracts in a Healthy Population